"Our practice specializes in the diagnosis and treatment of blood diseases (both malignant and benign) and cancer for patients 16 years and older. Our philosophy is that the most important aspect in the management of patients in our specialty involves advances, advocacy, and availability."

During the past decade, Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 7 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center" are "Breast Cancer" (7 trials), "Colorectal Cancer" (4 trials), "Extensive Stage Small Cell Lung Cancer" (1 trials), "Lymphoma" (1 trials) and "Metastatic Cancer" (1 trials). Many other conditions were trialed in "Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center" are "Drug" (12 trials), "Biological" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (3 trials), "cyclophosphamide" (3 trials), "fluorouracil" (2 trials), "paclitaxel" (2 trials) and "pegfilgrastim" (2 trials). Other intervention names were less common.

The vast majority of trials in "Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center" are 8 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".